Key In-vitro Diagnostics Market Players:
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Roche Diagnostics
- DiaSorin S. p. A.
- Johnson & Johnson corporation
- Becton, Dickinson and Company
- Siemens Healthineers
- Danaher Corporations
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Pfizer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of in-vitro diagnostics is evaluated at USD 108.06 billion.
In-vitro Diagnostics Market size was valued at USD 102.16 billion in 2024 and is set to exceed USD 197.24 billion by 2034, expanding at over 6.8% CAGR during the forecast period i.e., between 2025-2034.
North America is likely to hold largest industry share by 2034.
The key market players include Abbott Laboratories, Roche Diagnostics, DiaSorin S. p. A., Johnson & Johnson corporation, Becton, Dickinson and Company, Siemens Healthineers, Danaher Corporations, Bio-Rad Laboratories, Thermo Fisher Scientific, Pfizer Inc.
